BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10625949)

  • 1. Metabolism and cellular functions of IP6: a review.
    Shamsuddin AM
    Anticancer Res; 1999; 19(5A):3733-6. PubMed ID: 10625949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
    Saied IT; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
    Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
    Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IP6: a novel anti-cancer agent.
    Shamsuddin AM; Vucenik I; Cole KE
    Life Sci; 1997; 61(4):343-54. PubMed ID: 9244360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro.
    Shamsuddin AM; Yang GY; Vucenik I
    Anticancer Res; 1996; 16(6A):3287-92. PubMed ID: 9042302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cancer by dietary IP6 and inositol.
    Vucenik I; Shamsuddin AM
    Nutr Cancer; 2006; 55(2):109-25. PubMed ID: 17044765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
    Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary tumor inhibition by IP6: a review.
    Shamsuddin AM; Vucenik I
    Anticancer Res; 1999; 19(5A):3671-4. PubMed ID: 10625937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells.
    Cholewa K; Parfiniewicz B; Bednarek I; Swiatkowska L; Jezienicka E; Kierot J; Weglarz L
    Acta Pol Pharm; 2008; 65(1):75-9. PubMed ID: 18536177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer.
    Somasundar P; Riggs DR; Jackson BJ; Cunningham C; Vona-Davis L; McFadden DW
    J Surg Res; 2005 Jun; 126(2):199-203. PubMed ID: 15919420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
    Tantivejkul K; Vucenik I; Shamsuddin AM
    Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms for the antitumor activity of inositol hexakisphosphate (IP6).
    Bozsik A; Kökény S; Olah E
    Cancer Genomics Proteomics; 2007; 4(1):43-51. PubMed ID: 17726240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.
    Jariwalla RJ
    Anticancer Res; 1999; 19(5A):3699-702. PubMed ID: 10625943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of DMBA-induced mouse skin tumor development by inositol hexaphosphate and its mode of action.
    Gupta KP; Singh J; Bharathi R
    Nutr Cancer; 2003; 46(1):66-72. PubMed ID: 12925306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.
    Schröterová L; Hasková P; Rudolf E; Cervinka M
    Oncol Rep; 2010 Mar; 23(3):787-93. PubMed ID: 20127021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms.
    McFadden DW; Riggs DR; Jackson BJ; Cunningham C
    Oncol Rep; 2008 Feb; 19(2):563-6. PubMed ID: 18202808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inositol hexaphosphate on the inflammatory response in transformed RAW 264.7 macrophages.
    Johnson M; Tucci M; Benghuzzi H; Cason Z; Hughes J
    Biomed Sci Instrum; 2000; 36():21-6. PubMed ID: 10834203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma.
    Rizvi I; Riggs DR; Jackson BJ; Ng A; Cunningham C; McFadden DW
    J Surg Res; 2006 Jun; 133(1):3-6. PubMed ID: 16563438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.